Cannabis
Canada’s Green Gold: Cannabis Sales Bring $60 Million for Health Minister
As indicated by a recent report, fees related to cannabis activities have generated a revenue exceeding $60 million in the past year. However, this amount falls short of covering half of the Health Canada’s total operating costs. Also, legalization has not only resulted in a reduction of cannabis-related incidents among youth but has garnered support from both research and the activist community.
As a result of the legalization of cannabis in Canada, Health Canada, the federal health agency responsible for cannabis production licenses, has seen a significant increase in financial revenue. According to a recent report, cannabis-related fees brought in more than $60 million in revenue over the past year, less than half of the agency’s total operating costs of nearly $124 million.
Various types of application fees from producers, including fees of $1,765 for a micro or nursery license and $3,527 for a standard or medical-only license, brought in a total of $410,180. In addition, cannabis producers must pay a fee based on a portion of revenue, which helped generate an additional $55,894,055 in operating costs for the Health Canada agency.
If you want to find more details about the effects of cannabis legalization in Canada and read the most important cannabis news from around the world, download for free the Hemp.im mobile app.
Regulations and restrictions on cannabis sales
Existing fees for acquiring licenses and permits for cannabis-related activities are crucial to maintaining regulation and oversight of the market. The fee for a permit to import or export cannabis is $658 and brings in $946,464 in revenue.
Scheduled for April 2024, the license fee increases are intended to further support Health Canada’s regulatory and inspection activities. The fee for a micro or nursery license will increase to $1,969 and for a standard or medical-only license to $3,933.
Impact of cannabis legalization on society and public health
The legalization of cannabis in Canada has also had an impact on society and public health. In addition to the financial benefits to the government, the availability and regulation of cannabis consumption in Canada are closely monitored to ensure the safety and health of citizens.
Obtaining a license to cultivate medical cannabis and its use in treating various medical conditions is an important aspect of regulation in Canada. The cultivation and sale of cannabis for medical purposes must meet certain standards to ensure the quality and effectiveness of the product.
The decriminalization of Cannabis in Canada has yielded positive outcomes, particularly in diminishing confrontations between youth and law enforcement, as per research conducted by the Center for Addiction and Mental Health in Toronto. Published in the journal Drug and Alcohol Dependence, the study reveals a noteworthy decrease in marijuana-related offenses involving citizens aged 12 to 17.
Analyzing police data spanning from January 2015 to December 2021, researchers observed a substantial 62.1% reduction in cannabis-related incidents among young women and a 53% decline among young men. This decline coincided with the implementation of a law legalizing cannabis for adults aged 18 and over in Canada in October 2018.
—
(Featured image by Kindel Media via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Fintech1 week ago
The Fintech Sector Matures in 2024: €1.3B Raised Amid Mega-Deals Surge
-
Crypto3 hours ago
Quantum Stocks Are Exploding – But Don’t Miss This Trillion-Dollar RWA Opportunity
-
Biotech1 week ago
Roche Advances in Spectrometry with the Launch of Cobas Mass Spec
-
Crypto2 weeks ago
Bitcoin Weakens – Cardano, XRP, Tron and Others Lose a Lot of Ground